A de novo heterozygous germline STAT3 P715L mutation previously described (42–44) was identified in P18, presenting with life-threatening AIHA and other clinical findings associated with STAT3 gain-of-function (GOF) (44, 45). The gene discussed is STAT3; the disease is autoimmune hemolytic anemia.